VIDEO: A dystopian perspective on synbio and its underlying science and ethics. Not a view that Evolva shares.
You successfully joined our mailing list to receive Evolva's news releases via e-mail.
Join our mailing list to receive commercial updates via email. If you are interested in investor (“ad-hoc”) news instead, click the sign-up button on the Investor page.